Conference Coverage
about 23 hours ago
Top 5 Takeaways From ASCO 2026 That Patients Should KnowLatest Content
Jun 04, 2026 | News
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
Jun 03, 2026
Top 5 Takeaways From ASCO 2026 That Patients Should Know
Jun 03, 2026
If I Have Cancer Again
Jun 03, 2026
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
Jun 03, 2026
Advertisement
Shorts
0:54
ASCO 2026: The Biggest Advances in Cancer Care
a day ago
by
Quincy Attobrah
1:06
Week 6 Exercise of the Week Series ft. Dr. Leslie Waltke
5 days ago
by
Dr. Leslie Waltke
0:48
Your'e Never "too healthy" To Have Cancer
8 days ago
by
Diane Montalto
1:00
Week 5 Exercise of the Week Series ft. Dr. Leslie Waltke
13 days ago
by
Dr. Leslie Waltke
2:26
Week 4 Exercise of the Week Series ft. Dr. Leslie Waltke
19 days ago
by
Quincy Attobrah
1:03
Esophageal Cancer: Actions for Awareness
24 days ago
by
Dr. Sunil Dutta
1:02
The Silent Struggle of Being 'Cancer-Free'
24 days ago
by
Spencer Feldman
1:27
Week 3 Exercise of the Week Series ft. Dr. Leslie Waltke
a month ago
by
Quincy Attobrah
0:53
Week 2 Exercise Of The Week Series Ft. Dr. Leslie Waltke
a month ago
by
Quincy Attobrah
0:35
Why Therapists Belong in Oncology Clinics
a month ago
by
Ryan Scott
Podcasts
Videos
All News
Advertisement
Advertisement
FDA approved Cavhanza, a new nilotinib formulation for adults with Ph+ CML that may offer more flexible dosing and easier administration.
Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic triple-negative breast cancer.
A Lynch syndrome survivor shares essential prep tips, the importance of stomach cancer screening and how a mindset shift beats yearly scanxiety.
In a phase 3 study, Opdivo plus Yervoy did not improve overall survival when combined with chemotherapy for HER2-negative gastric or GEJ cancer.
Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies.
Kassiane Saieed explains how genomic tools provide data to help patients personalize their breast cancer treatment and survivorship.
Exercise after colon cancer chemotherapy reduced recurrence risk, improved survival and quality of life, according to the CHALLENGE trial.
Press Release
Triage Cancer's Beyond Diagnosis program provides free webinars, guidance, and support for parents living with metastatic cancer.
I thought I understood breast cancer, until a routine conversation at the pharmacy changed everything.
ASCO 2026: Telephone-based weight loss significantly improves physical function and mental health in patients with breast cancer patients who are overweight or obese.
Advertisement
A blood cancer survivor debunks the movie myth of a quick cure, exposing the harsh, lasting side effects that remain after ringing the bell.
Ivonescimab plus chemotherapy helped patients with advanced squamous NSCLC live longer than tislelizumab plus chemotherapy.
Giredestrant plus Afinitor improved disease control after later treatment and delayed chemotherapy in ER-positive, HER2-negative breast cancer.
Giredestrant plus Afinitor may help patients with metastatic breast cancer delay chemotherapy and stay on effective treatment longer.
Patients with cancer taking GLP-1 drugs alongside immunotherapy had better long-term survival and fewer immune-related side effects.